Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-16 | Mr. Wang LaiPresident and Global Head of Research & Development | -1,17k | 310,24k | Vente | 265,39 | 0,00 | -100,00% |
| 2026-06-16 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -590,00 | 156,93k | Vente | 265,98 | 0,00 | -100,00% |
| 2026-06-16 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -3,69k | 980,69k | Vente | 264,87 - 266,69 | 0,00 | -100,00% |
| 2026-06-16 | Dr. Xiaobin WuInitié | -1,36k | 362,00k | Vente | 266,76 | 16,37k | -7,66% |
| 2026-06-11 | Mr. Titus B. BallVP & CAO | -169,00 | 43,47k | Vente | 256,39 - 257,53 | 0,00 | -100,00% |
| 2026-06-11 | Mr. Wang LaiPresident and Global Head of Research & Development | -756,00 | 197,32k | Vente | 261,00 | 0,00 | -100,00% |
| 2026-06-11 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -1,95k | 501,35k | Vente | 256,23 - 258,81 | 0,00 | -100,00% |
| 2026-06-11 | Mr. Aaron RosenbergCFO | -631,00 | 162,64k | Vente | 257,74 | 0,00 | -100,00% |
| 2026-06-11 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -428,00 | 110,27k | Vente | 257,64 | 0,00 | -100,00% |
| 2026-06-11 | Dr. Xiaobin WuInitié | -626,00 | 163,51k | Vente | 261,20 | 16,37k | -3,68% |
| 2026-06-08 | Mr. Titus B. BallVP & CAO | -136,00 | 36,90k | Vente | 271,06 - 272,08 | 0,00 | -100,00% |
| 2026-06-08 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -871,00 | 235,54k | Vente | 270,24 - 271,26 | 0,00 | -100,00% |
| 2026-06-08 | Mr. Wang LaiPresident and Global Head of Research & Development | -1,37k | 368,25k | Vente | 269,34 - 270,73 | 0,00 | -100,00% |
| 2026-06-08 | Dr. Xiaobin WuInitié | -1,48k | 399,74k | Vente | 269,33 - 270,55 | 16,37k | -8,31% |
| 2026-06-08 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -4,94k | 1,34M | Vente | 270,38 - 271,14 | 0,00 | -100,00% |
| 2026-05-21 | Mr. Qingqing YiInitié | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 27,33k | 67,22% |
| 2026-06-01 | Mr. Qingqing YiInitié | -235,00 | 65,60k | Vente | 279,13 | 0,00 | -100,00% |
| 2026-05-21 | Dr. Corazon Dating SandersInitié | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 57,23k | 23,76% |
| 2026-05-21 | Dr. Alessandro RivaMember of Scientific Advisory Committee & Director | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 56,94k | 23,90% |
| 2026-05-21 | Dr. Margaret Han DuganMember of Scientific Advisory Committee & Independent Non-Exec. Director | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 56,94k | 23,90% |
| 2026-05-22 | Dr. Alessandro RivaMember of Scientific Advisory Committee & Director | -212,00 | 65,62k | Vente | 309,51 | 0,00 | -100,00% |
| 2026-05-22 | Dr. Margaret Han DuganMember of Scientific Advisory Committee & Independent Non-Exec. Director | -212,00 | 65,64k | Vente | 309,60 | 0,00 | -100,00% |
| 2026-05-22 | Dr. Corazon Dating SandersInitié | -212,00 | 65,63k | Vente | 309,59 | 0,00 | -100,00% |
| 2026-05-22 | Mr. Michael J. GollerInitié | -2,74k | 65,42k | Vente | 23,85 | 71,28k | -3,71% |
| 2026-05-22 | Mr. Ranjeev KrishanaInitié | -2,76k | 65,57k | Vente | 23,79 | 71,27k | -3,72% |
| 2026-05-21 | Mr. Michael J. GollerInitié | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 74,02k | 17,43% |
| 2026-05-21 | Mr. Ranjeev KrishanaInitié | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 74,02k | 17,43% |
| 2026-05-20 | Capital Research and Management CompanySociété | 72,54k | 21,91M | Achat | 302,13 | 6,54M | 1,12% |
| 2026-05-13 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -332,00 | 39,56k | Derivative Exercise and Sale | 159,03 - 310,72 | 0,00 | - |
| 2026-05-07 | JPMorgan Chase & Co.Société | 406,08k | 9,85M | Achat | 24,26 | 23,19k | -106,06% |
| 2026-05-05 | JPMorgan Chase & Co.Société | -706,53k | 15,88M | Vente | 22,47 | 119,23k | -85,56% |
| 2026-04-08 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -332,00 | 39,85k | Derivative Exercise and Sale | 159,03 - 311,59 | 0,00 | - |
| 2026-03-11 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -341,00 | 36,95k | Derivative Exercise and Sale | 159,03 - 300,00 | 0,00 | - |
| 2026-02-04 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -1,66k | 262,48k | Derivative Exercise and Sale | 159,03 - 350,00 | 0,00 | - |
| 2026-02-03 | JPMorgan Chase & Co.Société | 1,04M | 27,38M | Achat | 26,23 | 2,26M | 85,78% |
| 2026-01-15 | JPMorgan Chase & Co.Société | 35,57k | 938,72k | Achat | 26,39 | 236,26k | 17,73% |
| 2026-01-15 | JPMorgan Chase & Co.Société | 1,55M | 40,93M | Achat | 26,39 | 2,36M | 191,64% |
| 2026-01-15 | JPMorgan Chase & Co.Société | -191,33k | 5,05M | Vente | 26,39 | 2,36M | -7,50% |
| 2026-01-16 | JPMorgan Chase & Co.Société | 28,69k | 746,29k | Achat | 26,01 | 253,90k | 12,74% |
| 2026-01-16 | JPMorgan Chase & Co.Société | -117,00 | 3,04k | Vente | 26,01 | 253,90k | -0,05% |
| 2026-01-16 | JPMorgan Chase & Co.Société | -1,67M | 43,53M | Vente | 26,01 | 711,32k | -70,17% |
| 2026-01-14 | JP Morgan Asset ManagementSociété | -3,90k | 103,29k | Vente | 26,48 | 55,92k | -6,52% |
| 2026-01-14 | JPMorgan Chase & Co.Société | 9,25k | 245,09k | Achat | 26,48 | 202,24k | 4,80% |
| 2026-01-14 | JPMorgan Chase & Co.Société | -4,89k | 129,46k | Vente | 26,48 | 202,24k | -2,36% |
| 2026-01-14 | JPMorgan Chase & Co.Société | 167,86k | 4,45M | Achat | 26,48 | 783,04k | 27,29% |
| 2026-01-14 | JPMorgan Chase & Co.Société | -1,94M | 51,30M | Vente | 26,48 | 783,04k | -71,21% |
| 2026-01-08 | JPMorgan Chase & Co.Société | -546,40k | 0,00 | Other Disposition | - | 769,48k | -41,52% |
| 2026-01-07 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -664,00 | 93,09k | Derivative Exercise and Sale | 159,03 - 331,76 | 0,00 | - |
| 2025-12-31 | Mr. Anthony C. HooperChairman of Commercial & Medical Affairs Advisory Committee and Ind. Non Executive Director | 12,92k | 0,00 | Derivative Exercise and Retained Stock | - | 37,41k | 52,76% |
| 2025-12-19 | JPMorgan Chase & Co.Société | -140,55k | 0,00 | Other Disposition | - | 798,45k | -14,97% |
| 2025-12-16 | JPMorgan Chase & Co.Société | -762,99k | 0,00 | Other Disposition | - | 258,01k | -74,73% |
| 2025-12-16 | JPMorgan Chase & Co.Société | -15,81k | 0,00 | Other Disposition | - | 1,79M | -0,88% |
| 2025-12-15 | JPMorgan Chase & Co.Société | -598,45k | 0,00 | Other Disposition | - | 1,47M | -28,86% |
| 2025-12-11 | JP Morgan Asset ManagementSociété | -500,00 | 0,00 | Other Disposition | - | -500,00 | - |
| 2025-12-11 | JPMorgan Chase & Co.Société | -171,98k | 0,00 | Other Disposition | - | 1,04M | -14,20% |
| 2025-12-15 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -100,00k | 30,66M | Automatic Disposition | 300,80 - 314,92 | 0,00 | -100,00% |
| 2025-12-10 | JPMorgan Chase & Co.Société | -508,02k | 0,00 | Other Disposition | - | 1,40M | -26,65% |
| 2025-12-10 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -664,00 | 86,37k | Derivative Exercise and Sale | 159,03 - 325,00 | 0,00 | - |
| 2025-11-26 | Dr. Corazon Dating SandersInitié | -2,63k | 477,76k | Derivative Exercise and Sale | 159,03 - 342,47 | 0,00 | - |
| 2025-11-13 | JPMorgan Chase & Co.Société | -771,57k | 0,00 | Other Disposition | - | 2,48M | -23,73% |
| 2025-11-17 | Dr. Xiaobin WuInitié | -3,99k | 1,52M | Vente | 380,23 - 382,32 | 16,37k | -19,61% |
| 2025-11-12 | Dr. Xiaobin WuInitié | -16,01k | 5,85M | Vente | 350,44 - 381,05 | 16,37k | -49,45% |
| 2025-11-12 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -996,00 | 157,07k | Derivative Exercise and Sale | 159,03 - 350,00 | 0,00 | - |
| 2025-11-11 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -1,01M | 0,00 | Other Disposition | - | 51,48M | -1,92% |
| 2025-11-07 | Dr. Xiaodong WangCo-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder | -424,07k | 0,00 | Other Disposition | - | 9,32M | -4,35% |
| 2025-10-21 | JPMorgan Chase & Co.Société | -9,47k | 0,00 | Other Disposition | - | 1,59M | -0,59% |
| 2025-10-15 | JPMorgan Chase & Co.Société | -22,95k | 0,00 | Other Disposition | - | 270,26k | -7,83% |
| 2025-10-15 | JPMorgan Chase & Co.Société | -136,97k | 0,00 | Other Disposition | - | 1,54M | -8,19% |
| 2025-10-14 | JPMorgan Chase & Co.Société | -97,34k | 0,00 | Other Disposition | - | 271,74k | -26,37% |
| 2025-10-14 | JPMorgan Chase & Co.Société | -1,60k | 0,00 | Other Disposition | - | 1,54M | -0,10% |
| 2025-10-13 | JPMorgan Chase & Co.Société | -615,48k | 0,00 | Other Disposition | - | 1,52M | -28,79% |
| 2025-10-08 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -9,56k | 1,33M | Derivative Exercise and Sale | 159,03 - 351,12 | - | - |
| 2025-10-08 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -1,11k | 389,20k | Automatic Disposition | 350,00 | 0,00 | -100,00% |
| 2025-09-22 | JPMorgan Chase & Co.Société | -35,06k | 0,00 | Other Disposition | - | 277,27k | -11,23% |
| 2025-09-22 | JPMorgan Chase & Co.Société | -399,98k | 0,00 | Other Disposition | - | 2,06M | -16,24% |
| 2025-09-17 | JPMorgan Chase & Co.Société | -24,28k | 0,00 | Other Disposition | - | 274,35k | -8,13% |
| 2025-09-17 | JPMorgan Chase & Co.Société | -346,93k | 0,00 | Other Disposition | - | 1,95M | -15,10% |
| 2025-09-16 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -27,80k | 9,06M | Automatic Disposition | 324,12 - 327,78 | 0,00 | -100,00% |
| 2025-09-12 | JPMorgan Chase & Co.Société | -671,57k | 0,00 | Other Disposition | - | 1,75M | -27,70% |
| 2025-09-10 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -8,89k | 1,14M | Derivative Exercise and Sale | 159,03 - 327,93 | 0,00 | - |
| 2025-09-10 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -1,11k | 361,40k | Automatic Disposition | 325,00 | 0,00 | -100,00% |
| 2025-09-09 | JPMorgan Chase & Co.Société | -208,12k | 0,00 | Other Disposition | - | 1,73M | -10,76% |
| 2025-09-09 | Dr. Xiaodong WangCo-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder | -148,10k | 0,00 | Other Disposition | - | 9,74M | -1,50% |
| 2025-09-09 | Mr. Wang LaiPresident and Global Head of Research & Development | -5,00k | 1,75M | Automatic Disposition | 350,06 | 0,00 | -100,00% |
| 2025-09-09 | Capital Research and Management CompanySociété | 67,88k | 3,03M | Achat | 44,70 | 5,32M | 1,29% |
| 2025-09-05 | Dr. Corazon Dating SandersInitié | -2,67k | 483,22k | Derivative Exercise and Sale | 155,68 - 337,00 | 0,00 | - |
| 2025-09-02 | Mr. Titus B. BallVP & CAO | -122,00 | 39,86k | Vente | 326,76 | 0,00 | -100,00% |
| 2025-08-13 | Dr. Xiaobin WuInitié | -89,79k | 12,91M | Derivative Exercise and Sale | 155,68 - 308,03 | 16,37k | - |
| 2025-08-13 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -8,23k | 1,01M | Derivative Exercise and Sale | 159,03 - 301,00 | 0,00 | - |
| 2025-08-13 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -2,78k | 836,57k | Automatic Disposition | 300,00 - 301,00 | 0,00 | -100,00% |
| 2025-08-11 | Capital Research and Management CompanySociété | -55,08k | 15,89M | Vente | 288,52 | 5,21M | -1,05% |
| 2025-08-01 | Mr. Aaron RosenbergCFO | -1,19k | 345,66k | Vente | 290,47 | 0,00 | -100,00% |
| 2025-07-29 | Mr. Wang LaiPresident and Global Head of Research & Development | -4,30k | 1,30M | Automatic Disposition | 302,00 - 305,00 | 0,00 | -100,00% |
| 2025-07-30 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -920,00 | 280,23k | Vente | 304,60 | 0,00 | -100,00% |
| 2025-07-18 | Mr. Wang LaiPresident and Global Head of Research & Development | -700,00 | 210,00k | Automatic Disposition | 300,00 | 0,00 | -100,00% |
| 2025-07-17 | JPMorgan Chase & Co.Société | -794,20k | 0,00 | Other Disposition | - | 1,29M | -38,16% |
| 2025-07-09 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -27,80k | 7,04M | Automatic Disposition | 252,23 - 254,83 | 0,00 | -100,00% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
